QIL expands with larger offices and laboratory

QIL expands with larger offices and laboratory

In 2016, QIL, Quasar’s Israeli sister company, expend its offices and laboratory. This expansion is in line with Quasar’s growth and advancement within the medical market.
The new laboratory includes larger space and equipment used to support Quasar’s customers.
With the expended laboratory and engineering department Quasar will be able to support the growing needs from its customers.

Read More

China MAH Policy

China MAH Policy Changes and The massive Opportunity for Medical Device OEMs

The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical device companies. OEMs must capitalize on the major changes taking place in the Chinese market in allowing high-quality medical devices to be manufactured and marketed without as many restrictions as they experienced prior to the MAH Policy.

Read more...
crisis leadership

The Impact of Quasar’s Crisis Leadership Through Covid-19

As rumors of Covid-19 spread in January 2020, and fear gripped most of China, the management had to face facts and realize that a serious crisis was in the offing. Instead of being paralyzed by fear and uncertainty, Quasar’s leadership headed by Ayal Amitai, CEO, began looking ahead, considering courses of action to get the plant working again.

Read more...